advancing innovation to save lives

Meet the "Faces of Innovation" at ASTMH

GHTC launched a new blog series “Faces of Innovation” last week, on the sidelines of the American Society for Tropical Medicine and Hygiene (ASTMH) Annual Conference, to showcase the scientists on the front lines of research and development for new global health tools and technologies. 

GHTC honors Reps. Eshoo and Diaz-Balart and developers of RTS,S malaria vaccine

GHTC honored Congresswoman Anna Eshoo (D-CA) and Congressman Mario Diaz-Balart (R-FL) and the developers of the RTS,S malaria vaccine at its 2019 Innovating for Impact Awards, an initiative celebrating the US policymakers and partnerships driving global health innovation.
Learn More

Member Spotlight: RESULTS

RESULTS recently worked closely with offices of Senators Menendez and Young to ensure strong support for TB research was included in a new bill on global TB. Read more.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We bring together more than 25 nonprofit organizations, academic institutions, and aligned businesses to advance policies to accelerate the creation of new drugs, vaccines, diagnostics, and other tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity within reach for all people.

Learn more

PATH/Eric Becker
GHTC joins sign-on letter urging swift passage of FY20 appropriations bills to avoid negative consequences for science and research

GHTC joined 162 organizations in endorsing a letter to House and Senate leadership urging them to complete work on the fiscal year (FY) 2020 appropriations bills as soon as possible, given that the uncertainty created by short-term continuing resolutions can have “severe consequences for science and research.”


Homeland Preparedness News covers GHTC awards

Homeland Preparedness News covered GHTC's 2019 Innovating for Impact Awards, which honored Representatives Anna Eshoo (D-CA) and Mario Diaz-Balart (R-FL).

View All News & Events

Community Event

11th Annual CUGH Conference
Consortium of Universities for Global Health
Learn More
View All Events
PATH/Matthew Dakin
Explainer: the Nagoya Protocol and its impact on global health R&D

The World Health Organization recently announced that at its upcoming Executive Board meeting in February member states will discuss challenges and issues in implementing the Nagoya Protocol—a legal framework that governs the access to and benefits gained through the sharing of genetic resources including human and animal DNA, plants, and pathogens. As these discussions heat up, GHTC is taking a brief look at what the Nagoya Protocol is, how it impacts global health R&D, and what’s next for the future of this framework.

Read More
Faces of Innovation: Dr. Rohit Ramchandani, researcher at the Johns Hopkins University and the University of Waterloo

Faces of Innovation—a new GHTC project that features scientists on the front lines of research and development on new global health tools and technologies—profiles Dr. Rohit Ramchandani, who we met at the American Society of Tropical Medicine and Hygiene Annual Conferenc. Dr. Ramchandani does research to innovate global treatment options for childhood diarrhea at the Johns Hopkins School of Public Health in Baltimore, Maryland and the University of Waterloo. 

Read More
View Breakthroughs Blog

Our members work to improve health worldwide